Intepirdine as adjunctive therapy to donepezil for mild-to-moderate Alzheimer's disease: A randomized, placebo-controlled, phase 3 clinical trial (MINDSET)
Published inAlzheimer's & dementia. Translational research & clinical interventions, vol. 7, no. 1, e12136
Publication date2021
First online date2021-05-31
Abstract
Keywords
- 5‐HT6
- Alzheimer's disease
- Clinical trial
- Intepirdine
- Phase 3
Citation (ISO format)
LANG, Frederick M et al. Intepirdine as adjunctive therapy to donepezil for mild-to-moderate Alzheimer’s disease: A randomized, placebo-controlled, phase 3 clinical trial (MINDSET). In: Alzheimer’s & dementia. Translational research & clinical interventions, 2021, vol. 7, n° 1, p. e12136. doi: 10.1002/trc2.12136
Main files (1)
Article (Published version)
Secondary files (4)
Identifiers
- PID : unige:169947
- DOI : 10.1002/trc2.12136
- PMID : 34095437
- PMCID : PMC8165732
ISSN of the journal2352-8737